CSI Market
Sign In | Register

Tengjun Biotechnology (CHGH) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CHGH quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Tengjun Biotechnology balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Operating Activities
Income11.97
Depreciation & amortization0.31
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.76
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories1.85
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Allowance For Obselate Inventory0.04
Income taxes23.55
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Receivables-43.26
Increase (Decrease) in Accounts Payable5.44
Increase (Decrease) in Accrued Liabilities-0.06
Deferred Revenue and Customer Advances and Deposits0.10
Increase (Decrease) in Prepaid Taxes0.65
Other Working Capital0.00
Other Noncash Income0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities1.35
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment For Construction In Progress0.02
Cash Receipt From Reverse Merger-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments-0.52
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.50
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-3.78
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.55
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Debt Instrument Decrease Forgiveness-
Proceeds Received As Advance For Future Common Stock Subscriptions-
Refundforadvanceforfuturecommonstocksubscription-
Repayment Of Proceeds From Shortterm Bank Loan-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.78
Effect of exchange rate on cash flow-0.07
Discontinued operations0.00
Free Cash Flow1.34
Total Cash Flow2.55
4 historic quarters locked

Sign in to unlock the full Tengjun Biotechnology cash flow history.

Sign In Create Free Account

About Tengjun Biotechnology Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-23-067340

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License